A comprehensive approach to reduce harm for people who inject drugs
In pursuit of a one-stop shop: a hybrid type 1 effectiveness-implementation trial of comprehensive tele-harm reduction for people who inject drugs
['FUNDING_R01'] · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · NIH-11082326
This study is creating a friendly program to help people who inject drugs by offering easy access to important health services like HIV testing and clean syringes, all in a supportive environment that understands their challenges.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF MIAMI SCHOOL OF MEDICINE (nih funded) |
| Locations | 1 site (CORAL GABLES, UNITED STATES) |
| Trial ID | NIH-11082326 on ClinicalTrials.gov |
What this research studies
This research aims to develop and test a comprehensive tele-harm reduction program specifically designed for people who inject drugs (PWID). It focuses on integrating various healthcare services, including rapid HIV testing, antiretroviral therapy, and syringe services, into a single, accessible model. The program will be implemented in supportive environments that address the stigma and discrimination faced by PWID, while also tackling related health issues such as hepatitis C and overdose. By utilizing a hybrid effectiveness-implementation trial, the research seeks to evaluate the feasibility and acceptability of this approach among the target population.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who inject drugs and are at risk for HIV and other related health conditions.
Not a fit: Patients who do not inject drugs or are not at risk for HIV may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly reduce HIV infections and improve overall health outcomes for people who inject drugs.
How similar studies have performed: Previous research has shown success with integrated healthcare models for PWID, indicating potential for this comprehensive approach.
Where this research is happening
CORAL GABLES, UNITED STATES
- UNIVERSITY OF MIAMI SCHOOL OF MEDICINE — CORAL GABLES, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: TOOKES, HANSEL EMORY — UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
- Study coordinator: TOOKES, HANSEL EMORY
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Acquired Immune Deficiency Syndrome Virus, Acquired Immunodeficiency Syndrome Virus